The global market of Vitamin B9 has observed a decrease of 5% in the first half of September 2025. The decline in Vitamin B9 market was driven by strategic pricing decisions from suppliers. The suppliers have softened their prices to stimulate the buying interest of importers have further contributed to a price drop. The domestic sectors in China have halted their procurement mid-September in anticipation of the Golden Week celebrations in early October which will temporarily slowdown the downstream production runs. The dynamics of supply and demand with the anticipation of upcoming production cycles have resulted in the market volatility. The adjustment in prices have reflected the interconnectedness of supply chain dynamics, inventory levels and seasonal shifts in demand across different markets. The demand will experience an uptick with anticipated growth in the pharmaceutical and nutraceutical markets for prenatal and standalone vitamins. ChemAnalyst further advises the stakeholders to diversify their sourcing strategies and maximize their benefits during this anticipatory period.
